Vaccine stock to climb up to $140 in wave-3
Updated
At a weekly time frame, this stock is the next thing to blow out. With phase 3 trials expected in July, the potential of 
MRNA could be huge in upcoming weeks.
With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
MRNA could be huge in upcoming weeks.With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
Trade active
Trade closed manually
Trade was closed earlier in August when MRNA made a high of $95.21 and then dropped back to 60s breaking the trend line.Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.